革新医疗事务-我们已准备好与您携手，重新定义医疗参与的未来

Revolutionizing Medical Affairs We are ready to redefine the future of medicalengagement with you •Unified global data fabric•Forward-thinking innovation•Integrated technology Unlock the power of KOL collaboration:transforming expertise into impact FPOPartnering with Key Opinion Leaders (KOLs), typically thought leaders in theirrespective fields, is crucial for driving innovation and enhancing credibility withinthe life sciences. In the pharmaceutical industry, thought leaders are referred toby various names depending on the company. Common terms include KOL (KeyOpinion Leader), EE (External Expert), KEE (Key External Expert), TL (ThoughtLeader), and SE (Scientific Expert). Despite the different titles, they all represent thesame concept of leveraging the expertise and influence of respected professionals.Effective Thought Leader Engagement (TLE) educates the medical community,fosters trust, and ultimately benefits patients, and is essential for successfulproduct launches and swift commercial success. While many pharmaceuticalcompanies want to invest in TLE, they struggle with where to start and how todemonstrate its impact. Challenges include identifying the right KOLs, maintainingauthentic partnerships, ensuring regulatory compliance, and balancing short-termand long-term strategies. The risks of ineffective TLE Without robust TLE solutions, pharmaceutical companies encounter difficulties in effectively engaging KOLs dueto unharmonized data, ineffective engagement methods, and lack of actionable insights. These issues result insuboptimal strategies and limited flexibility in managing growing needs and market shifts towards more scientificallydriven conversations. Consequently, companies miss opportunities for innovation, minimizing the alignment betweenproducts and real-world needs and reducing their ability to shape industry conversations and stay competitive.Investing in effective TLE tools is essential to avoid these pitfalls and to ensure sustained growth and impact. Pharmacompanies that prioritize executing well with structured TLE strategies often report enhanced product adoption rates,more successful product launches, and stronger stakeholder trust. Lack of integration of HCP insights in planning Limited activity coordination Inability to seamlessly identify HCPs, search and filterbased on comprehensive profile and engagementdata, as well as apply AI/ML-driven insights. Lack of impact understanding Few visualizations available for executive andstrategic decisions while unclear impact metricsinhibit synthesis of multiple applicable TA dimensions. Comprehensive solutions for strategic ThoughtLeader Engagement IQVIA’s thought leader engagement offering provides a comprehensive solution for identifying the right expertsby leveraging scientific, clinical, digital, and peer learning data combined with the customer’s own KOL activitiesand other third-party data to pinpoint KOLs who align with strategic goals. The solution supports identifyingbusiness needs, strategic planning of KOL engagement across congresses, advisory boards, leadership meetings,etc., and allows for the alignment of KOLs to engagement activities. It ensures effective collaboration by balancingplanned, contracted activities such as advisory boards with flexible, ad hoc engagements like informal consultations,seamlessly involving multiple team members for a holistic approach. The IQVIA Clinical Expert module uses real-world dataand analytics to identify and connect with clinical expertsglobally. It ranks experts, visualizes networks, and tracksclinical activities, supporting medical and commercialefforts with a comprehensive view of leadership. The IQVIA Scientific Expert module identifies and ranksscientific experts globally using real-world data andanalytics. It optimizes KOL activities, visualizes HCPcollaborations, and supports strategic decisions acrossthe product lifecycle. The IQVIA Digital Expert module identifies andranks Digital Opinion Leaders (DOLs) usingdata from X (Twitter) and LinkedIn, supportingmedical and commercial efforts by integrating thisinformation with scientific and clinical profiles. The IQVIA Activating Thought Leader Networksmodule identifies and engages Thought Leadersto optimize product launch and commercialization,integrating multiple data sources for precisetargeting and coordinated engagement. The solution helps simplify and enhance KOLengagement planning at congresses, includingscheduling, coordination, and preparation prior to thecongresses, as well as in-flight course corrections suchas addressing results of real-time congress insights andsentiment analysis. Finally, measuring the activities andimpact helps with future strategic planning and timelyactionable suggestions through Next Best ScientificAction. To showcase results and maximize impact,IQVIA employs innovative tools and analytics, deliveringmeasurable insights into the effectiveness and value ofengagement efforts. Medical e